Fluid Challenges in Intensive Care (FENICE)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01787071 |
Recruitment Status :
Completed
First Posted : February 8, 2013
Last Update Posted : August 20, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Fluids are one of most common therapies used in critically ill patients. Fluids are the cornerstone of hemodynamic management. In overt bleeding, fluids are often given without guidance with specific haemodynamic monitoring. In other conditions when hypovolemia may be more subtle or when the response to fluids is more variable, fluids are often given in a more titrable way, monitoring their haemodynamic impact. This practice, called the fluid challenge technique has been proposed by Max Harry Weil more than 30 years ago [1].
The fluid challenge has been used in several papers and studies assessing the response of patients to fluids. The way this practice is performed varies in terms of type of fluid, volume of fluid, rate of fluid administration, and clinical endpoints used.
There is no data that describe how fluid challenges are administered in ICU's across the world. Understanding this will provide valuable information regarding current practice and would be a basis for improving current practice and future research.
The way fluids are administered vary widely. Indications for fluids and monitoring of the effects are not standardized and may thus lead to heterogeneity in practice. In addition, several patients may fail to respond to fluids. The purpose of this observational study is to evaluate how fluids are administered and to identify the factors associated with a positive response to fluids. Better characterizing these practices and the patients who benefit from fluids would set the basis of further interventional trials trying to optimize fluid administration.
What does this study involve?
- All patients enrolled in the study will receive standard clinical care
- Data will be collected in order to study how fluid challenges are performed in ICU's
- No extra tests will be performed for this study
- Only measurements and data available as part of clinical practice will be collected
Condition or disease | Intervention/treatment |
---|---|
Focus: Fluid Challenge | Other: Fluid challenge |

Study Type : | Observational |
Actual Enrollment : | 2304 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | How do we Administer Fluids in the ICU? |
Study Start Date : | April 2013 |
Actual Primary Completion Date : | December 2013 |
Actual Study Completion Date : | December 2013 |
Group/Cohort | Intervention/treatment |
---|---|
one group
Patients receiving fluid challebnge
|
Other: Fluid challenge
Administration of red blood cell transfusions or fresh frozen plasma is not considered as a fluid challenge.
Other Name: For the purpose of this study a fluid challenge is defined as administration of any bolus of fluid (crystalloid or colloid) in less than two hours. |
- Number of patients in whom functional hemodynamic variables are used to indicate fluid challenge. [ Time Frame: 1 week ]
- Number of patients responding to fluids, number of patients presenting contra-indication to functional hemodynamic variables. [ Time Frame: one week ]
- number of patients responding to fluids according to time from admission in ICU [ Time Frame: one week ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- All consecutive adult (18 years old and above) patients , up to a maximum of 20, in whom a fluid challenge is performed during a one week period will be included
Exclusion Criteria:
- 1/ Patient already included in the trial
- 2/ Overt bleeding Patients younger than 18 year

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01787071
Belgium | |
All Centres Willing to Contribute Are Welcome | |
Brussels, Belgium |
Principal Investigator: | Daniel De Backer, MD,PhD | Erasme University Hospital, Brussels |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Guy FRANCOIS, ESICM Trials Group, European Society of Intensive Care Medicine |
ClinicalTrials.gov Identifier: | NCT01787071 |
Other Study ID Numbers: |
FENICE |
First Posted: | February 8, 2013 Key Record Dates |
Last Update Posted: | August 20, 2014 |
Last Verified: | August 2014 |
fluids crtically ill patients functional hemodynamics cvp |